"the funding that’s the problem"
no its not
Its despite having "two world class FDA /CE approved products " and they still need funding is the problem.
They cant even keep their shares trading on the market.
Ann: Extension for Voluntary Suspension, page-220
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.09 |
Change
-0.210(1.37%) |
Mkt cap ! $318.9M | |||
| Open | High | Low | Value | Volume |
| $15.10 | $15.38 | $15.02 | $55.26K | 3.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 98 | $15.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.57 | 779 | 1 |
View Market Depth
| Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |